COMT and breast cancer: Accumulation of 4-OHE2, due to decreased COMT activity, is hypothesized to confer increased risk for breast cancer suggesting that a polymorphism in COMT is associated with increased risk of breast cancer, however, some studies suggest that a COMT polymorphism is not linked with breast cancer [227,232,237,241].